Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease.

@article{Zhuge2018ClinicalCA,
  title={Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease.},
  author={Yu Z Zhuge and Yi Wang and Feng Zhang and Cheng K Zhu and Wei Zhang and Ming Zhang and Qibin He and Jian Yang and Jian He and Jun Chen and Xiaoping Zou},
  journal={Liver international : official journal of the International Association for the Study of the Liver},
  year={2018},
  volume={38 10},
  pages={
          1867-1874
        }
}
BACKGROUND AND AIMS Hematopoietic stem cell transplantation related hepatic vein occlusive disease (HSCT-HVOD) has been researched extensively; however, little is known about the clinical features and treatment of pyrrolizidine alkaloid-induced HVOD (PA-HVOD). This retrospective single centre study examined the clinical and laboratory characteristics of 108 patients with acute PA-HVOD and explored the efficacy of anticoagulation and TIPS therapy. METHODS The study included 108 consecutive… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 2 times. VIEW TWEETS